Form 8-K - Current report:
SEC Accession No. 0001102624-04-000061
Filing Date
2004-04-20
Accepted
2004-04-20 14:17:50
Documents
2
Period of Report
2004-04-20
Items
Item 12: Results of Operations and Financial Condition
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 IMMUCELL CORP 8-K immucellcorp8k.htm 8-K 3191
3 IMMUCELL CORP PRESS RELEASE immucellcorporation.htm EX-99.1 CHARTER 5511
  Complete submission text file 0001102624-04-000061.txt   10396
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

IRS No.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12934 | Film No.: 04742519
SIC: 2835 In Vitro & In Vivo Diagnostic Substances